Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 5 of 10

DFC JWCI-18-0401 - John Wayne Cancer Institute Biospecimen and Research Data Repository

The purpose of this study is to collect clinical data and biological specimens (e.g., blood, tumor,cerebrospinal fluid, urine sample, etc.) from...

Jennifer Linehan, M.D.
  • Disney Family Cancer Center (DFCC)
  • John Wayne Cancer Institute (JWCI)
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

JWC JWCI-18-0401 - John Wayne Cancer Institute Biospecimen and Research Data Repository

The purpose of this study is to collect clinical data and biological specimens (e.g., blood, tumor,cerebrospinal fluid, urine sample, etc.) from...

Jennifer Linehan, M.D.
  • John Wayne Cancer Institute (JWCI)
  • Providence St. Johns Health Center (PSJHC)

John Wayne Cancer Institute Biospecimen Repository

Jose Esteban, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy in the Treatment of Patients of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Inclusion Criteria:Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

DFC MK3475 671 - A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy +/- Pembrolizumab (MK-3475) as Neoadjuvant/Adjuvant Therapy for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (NSCLC) (KEYNOTE-671)

This is a Phase III, Randomized, Double-blind Trial of Chemo +/- Pembrolizumab (MK-3475) as Perioperative Therapy in patients with histologically...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 5 of 10